Adaptive symptoms: gastrointestinal stromal carcinoma, advanced renal cell carcinoma
Pharmacology: Small molecules that inhibit multiple receptor tyrosine kinases (RTK), some of which are involved in tumor growth, pathologic angiogenesis, and tumor metastasis